Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ionis
Pharma
As questions swirl, Alnylam eyes ATTR market leadership by 2030
Alnylam aspires for Amvuttra to become the revenue leader in an expansive ATTR-CM market of more than 75,000 U.S.-treated patients by 2030.
Angus Liu
Mar 26, 2026 2:08pm
JPM26, Day 2: Novo CEO talks 'mastering' cash pay sales in '26
Jan 13, 2026 7:29pm
Ionis doubles its sales projection for Tryngolza in sHTG to $2B
Jan 13, 2026 3:45pm
Arrowhead strikes true with first FDA approval
Nov 18, 2025 3:44pm
Ionis' Tryngolza win in sHTG sends shares soaring by 27%
Sep 2, 2025 11:30am
Ionis, Arrowhead sponsor new triglyceride education group
Mar 28, 2025 10:10am
